The Simmons Hanly Conroy is once again sponsoring the annual Malignant Mesothelioma Symposium, a conference for the entire mesothelioma community
As part of Simmons Hanly Conroy’s efforts to support mesothelioma research and raise asbestos awareness, the firm is once again partnering with Mesothelioma Applied Research Foundation to sponsor the 11th annual Malignant Mesothelioma Symposium. The symposium, held this year from June 23-25 at the Omni Shoreham Hotel in Washington, D.C., features sessions with some of the nation’s leading mesothelioma doctors and advocates.
This year, Simmons Hanly Conroy Shareholder John Barnerd will participate in a panel to answer questions about the legal process for mesothelioma victims. The discussion will take place from 5:45 – 6:45 pm on June 23.
“The symposium provides a perfect opportunity for patients and their families to connect with each other and stay up-to-date on the latest medical research,” said Joy Wheeler, Simmons Hanly Conroy’s vice president of medical and patient relations. “As an advocate for victims of mesothelioma, we work to support the mesothelioma community in any way we can.”
The Simmons Hanly Conroy’s sponsorship of the Malignant Mesothelioma Symposium is the latest in the firm’s ongoing support of mesothelioma research. To date, Simmons Hanly Conroy has donated over $2 million to the Mesothelioma Applied Research Foundation, making it the research foundation’s top cumulative donor.
“Through events like the annual Malignant Mesothelioma Symposium, the Mesothelioma Applied Research Foundation has been a leader in the fight against asbestos-related disease,” said John Simmons, founding Shareholder of Simmons Hanly Conroy. “We are proud to team up with the foundation as they bring us closer to a cure.”
Register for the symposium and find a schedule of events through the Mesothelioma Applied Research Foundation.
